Internal Medicine, Hematology & Oncology · Chambersburg, PA
NPI
1790787232
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
22 St Paul Dr
Chambersburg, PA, 17201
Phone (717) 217-6020
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
127,832 services
Medicare patients, 2024
372
Average age 75
Drug cost, 2024
$4.8M
1,076 prescriptions
Company payments, 2025
$199
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose Silva was code J9271 (injection, pembrolizumab, 1 mg), 8,200 times for 15 patients. In total Jose Silva billed 127,832 services in 110 codes, and Medicare paid $1.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 8,200 | 15 | $44.86 | $368K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 7,650 | 13 | $0.27 | $2,094 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,150 | 17 | $0.11 | $682 |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,460 | 15 | $0.08 | $439 |
| J0897 Injection, denosumab, 1 mg | Office | 4,441 | 21 | $20.53 | $91K |
| J1756 Injection, iron sucrose, 1 mg | Office | 3,900 | 13 | $0.18 | $699 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2,701 | 16 | $5.85 | $16K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,862 | 51 | $0.09 | $169 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 770 | 30 | $0.77 | $591 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 684 | 27 | $0.07 | $50.03 |
| 99214 Office E&M - Established | Office | 322 | 115 | $96.03 | $31K |
| 96375 Injection Administration | Office | 303 | 62 | $11.28 | $3,419 |
| 96372 Injection Administration | Office | 287 | 80 | $10.66 | $3,059 |
| 96413 Chemotherapy Administration | Office | 255 | 77 | $94.16 | $24K |
| 96367 Intravenous Infusion, Hydration | Office | 181 | 52 | $20.86 | $3,776 |
By year: 2022 $48K for 2,187 services; 2023 $1.5M for 108,203 services; 2024 $1.9M for 127,832 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose Silva prescribed most often to Medicare patients was Dexamethasone, with 115 prescriptions and refills. In total Jose Silva wrote 1,076 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dexamethasone Generic | 115 | 127 | 25 | $937 |
| Anastrozole Generic | 95 | 175 | 28 | $1,666 |
| Ondansetron Hcl Generic | 73 | 73 | 49 | $633 |
| Potassium Chloride Generic | 66 | 70 | 15 | $1,193 |
| Hydroxyurea Generic | 60 | 77 | Under 11 | $424 |
| Letrozole Generic | 53 | 115 | 14 | $1,482 |
| Acyclovir Generic | 51 | 56 | Under 11 | $717 |
| Revlimid Lenalidomide | 47 | 47 | Under 11 | $852K |
| Xtandi Enzalutamide | 35 | 35 | Under 11 | $469K |
| Lenalidomide Generic | 31 | 31 | Under 11 | $371K |
| Ibrance Palbociclib | 27 | 27 | Under 11 | $430K |
| Calquence Acalabrutinib Maleate | 26 | 26 | Under 11 | $377K |
| Exemestane Generic | 24 | 38 | Under 11 | $2,535 |
| Xarelto Rivaroxaban | 21 | 23 | Under 11 | $11K |
| Tamoxifen Citrate Generic | 19 | 21 | Under 11 | $56.29 |
Brand drugs: 293 claims; generic drugs: 783 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose Silva $199 ($199 in general payments such as food, travel and fees) from 4 companies. The largest payer was Eisai Inc. with $91.89.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.